Arno Therapeutics Engages the Ruth Group for Investor Relations and Public Relations Counsel

Published: Mar 19, 2013

FLEMINGTON, N.J., March 19, 2013 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCBB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that the company has engaged The Ruth Group as its public relations and investor relations agency of record.

Back to news